This may be the end, although G says he's not giving up.

Note 9 – Subsequent Events On August 15, 2022, the Company received a notice from the Convertible Note Holders that the CRO VC had terminated discussions and was no longer interested in completing the transaction described in the Term Sheet. As a result, the Company and the Convertible Note Holders are currently negotiating a settlement of the convertible notes. On October 3, 2022, the Company received a termination notice from Psychogenics, Inc. with respect to the eltoprazine license agreement. The Company is currently evaluating its legal options.